Markets

HCW Biologics Announces It Secured $10M In Cash To Finance Its Phase 1 Trial Of HCW9302 To Treat Alopecia Areata

Nov 5, 2026 · 08:47 AM ET· updated 1h ago

HCW Biologics Inc. (the "Company" or "HCW Biologics") (NASDAQ:HCWB), a U.S.-based clinical-stage biopharmaceutical company and leading developer in novel multi-functional fusion immunotherapeutics, for

Why It Matters

HCW Biologics raised ten million dollars to test a new hair loss medicine. This means the company has money to keep working on their science project.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

HCWB1.04

-0.04 (-3.70%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.